文献速递头颈与中枢神经肿瘤

转移和复发性涎腺癌的综合基因组图谱与肿瘤类型相关并揭示靶向治疗新路径

Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies.
PubMed 文献 · Ann Oncol · 2017-01-01

该研究对623例连续涎腺癌(SGC)FFPE样本进行综合基因组分析(CGP),覆盖最多315个癌症相关基因,平均测序深度>500×,肿瘤突变负荷在1.1 Mb测序DNA上确定。结果发现,临床较惰性的SGC(如腺样囊性癌等)比更具侵袭性的SGC(如黏液表皮样癌、涎腺导管癌等)具有显著更少的基因组改变、TP53突变和更低的肿瘤突变负荷;侵袭性SGC常由ERBB2 PI3K通路基因组改变驱动,且常可见其他可靶向的基因组改变。结论认为基因组分析揭示了惰性与侵袭性SGC之间的重要差异,可能为未来提供治疗选择。

要点

  • 惰性SGC(腺样囊性癌等)较侵袭性SGC(黏液表皮样癌等)基因组改变更少、TP53突变更少、TMB更低。
  • 侵袭性SGC常由ERBB2 PI3K通路基因组改变驱动,并频繁出现其他可靶向改变。
  • 综合基因组分析可区分SGC亚型并揭示潜在靶向治疗路径。

核心结论

  • SGC的基因组分析显示传统惰性与侵袭性癌症之间存在重要差异,这些差异可能在未来提供治疗选择。

研究设计与样本

  • 从85 686例临床病例系列中提取623例连续SGC的FFPE样本DNA,进行杂交捕获、接头连接文库的综合基因组分析(平均覆盖深度>500×),覆盖最多315个癌症相关基因,肿瘤突变负荷在1.1 Mb测序DNA上确定。

主要发现

  • 临床更惰性的SGC(包括腺样囊性癌、腺泡细胞癌、多形性低度恶性腺癌、乳腺类似分泌癌和上皮-肌上皮癌)比通常更具侵袭性的SGC(包括黏液表皮样癌、涎腺导管癌、腺癌非特指型、癌非特指型和多形性腺瘤癌变)具有显著更少的基因组改变、TP53突变和更低的肿瘤突变负荷。
  • 更具侵袭性的SGC常由ERBB2 PI3K通路基因组改变驱动。
  • 常可见其他可靶向的基因组改变。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Relapsed/metastatic salivary gland carcinomas (SGCs) have a wide diversity of histologic subtypes associated with variable clinical aggressiveness and response to local and systemic therapies. We queried whether comprehensive genomic profiling could define the tumor subtypes and uncover clinically relevant genomic alterations, revealing new routes to targeted therapies for patients with relapsed and metastatic disease. PATIENTS AND METHODS: From a series of 85 686 clinical cases, DNA was extracted from 40 µm of formalin-fixed paraffin embedded (FFPE) sections for 623 consecutive SGC. CGP was carried out on hybridization-captured, adaptor ligation-based libraries (mean coverage depth, >500×) for up to 315 cancer-related genes. Tumor mutational burden was determined on 1.1 Mb of sequenced DNA. All classes of alterations, base substitutions, short insertions/deletions, copy number changes, and rearrangements/fusions were determined simultaneously. RESULTS: The clinically more indolent SGC including adenoid cystic carcinoma, acinic cell carcinoma, polymorphous low-grade adenocarcinoma, mammary analog secretory carcinoma, and epithelial-myoepithelial carcinomas have significantly fewer genomic alterations, TP53 mutations, and lower tumor mutational burden than the typically more aggressive SGCs including mucoepidermoid carcinoma, salivary duct carcinoma, adenocarcinoma, not otherwise specified, carcinoma NOS, and carcinoma ex pleomorphic adenoma. The more aggressive SGCs are commonly driven by ERBB2 PI3K pathway genomic alterations. Additional targetable GAs are frequently seen. CONCLUSIONS: Genomic profiling of SGCs demonstrates important differences between traditionally indolent and aggressive cancers. These differences may provide therapeutic options in the future.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Ross JS, Gay LM, Wang K, et al. Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies. Ann Oncol. 2017. PMID: 28961851. doi:10.1093/annonc/mdx399

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。